Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOVO-MISOPROSTOL TABLETS 100 MCG

MISOPROSTOL : 100 MCG · DIN 02240754 · NOVOPHARM LIMITED

Health Canada status: CANCELLED POST MARKET

What is NOVO-MISOPROSTOL TABLETS?

NOVO-MISOPROSTOL TABLETS 100 MCG contains MISOPROSTOL : 100 MCG. It is listed in the Health Canada Drug Product Database under DIN 02240754, held by NOVOPHARM LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 18-May-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02240754
Brand nameNOVO-MISOPROSTOL TABLETS
Generic / active ingredientMISOPROSTOL : 100 MCG
ManufacturerNOVOPHARM LIMITED
Strength100 MCG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeA02BB01 MISOPROSTOL
AHFS class56:28.28
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date18-May-2018
Original market date2001-11-15 00:00:00

Is MISOPROSTOL in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by AA PHARMA INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for NOVO-MISOPROSTOL TABLETS

What can be used instead?

Other Canadian products sharing ATC code A02BB01 MISOPROSTOL. 2 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
MISOPROSTOL100 MCGTABLETAA PHARMA INCMARKETEDDIN 02244022
MISOPROSTOL200 MCGTABLETAA PHARMA INCMARKETEDDIN 02244023
CYTOTEC 100 MCG100 MCGTABLETPFIZER CANADA ULCCANCELLED POST MARKETDIN 00813966
CYTOTEC 200 MCG200 MCGTABLETPFIZER CANADA ULCCANCELLED POST MARKETDIN 00632600
JAMP MISOPROSTOL200 MCGTABLETJAMP PHARMA CORPORATIONAPPROVEDDIN 02545284
MISOPROSTOL-200200 MCGTABLETPRO DOC LIMITEECANCELLED POST MARKETDIN 02248846
NOVO-MISOPROSTOL TABLETS200 MCGTABLETNOVOPHARM LIMITEDCANCELLED POST MARKETDIN 02240755
PMS-MISOPROSTOL (0.1MG)100 MCGTABLETPHARMASCIENCE INCCANCELLED POST MARKETDIN 02244124
PMS-MISOPROSTOL (0.2MG)200 MCGTABLETPHARMASCIENCE INCCANCELLED POST MARKETDIN 02244125

Who else supplies MISOPROSTOL worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. MISOPROSTOL appears in 17 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for NOVO-MISOPROSTOL TABLETS

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for NOVO-MISOPROSTOL TABLETS

Health Canada Drug Product Database (DPD), DIN 02240754. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.